期刊文献+

β-联蛋白在结肠癌中的表达及其临床意义

Expression and clinical significance of P-catenin in colon carcinoma
暂未订购
导出
摘要 目的探讨β-联蛋白与结肠癌发生、发展以及转移的关系。方法利用组织芯片技术,采用免疫组化(S P)法检测62例结肠癌、18例结肠腺瘤和10例正常结肠组织中β-联蛋白(β-catenin)基因蛋白产物的表达水平。结果结肠癌和结肠腺瘤组织中β-catenin的异常表达率分别为80.6%和83.3%,均显著高于正常组织的表达率0.0%, 差异有显著性(P<0.01)。腺癌组与腺瘤组异常表达率差异无显著性(P>0.05)。低分化组异常表达率(87.2%) 明显高于高分化组(60.0%)(P<0.05)。淋巴结转移组异常表达率(92.5%)显著高于无淋巴结转移组(59.0%)(P <0.01)。β-catenin异常表达与肿瘤浸润深度和肿瘤大小无关(P>0.05)。结论β-catenin的异常表达与结肠癌的分化和转移有关,是肿瘤发生、发展及转移的一个重要因素,可作为结肠癌是否具有恶性潜能的一个重要参考指标。 Objective To study the expression and clinical significance of β-catenin in colon carcinoma. Methods Specimens from colon carcinoma (62 cases), colonadenoma ( 18 cases) and normal colon tissues ( 10 cases) for which tissue microarrays were constructed and used for immunohistochemical detection of β-catenin protein expression. Results Immunohistochemical analysis of tissue microarrays demonstrated β-catenin protein expression in 80.6 % of the colon carcinoma and in 83.3 % of colon adenoma. The expression of β-catenin was higher than that of normal tissues( P 〈 0.01 ), while between colon carcinoma and colon adenoma, being of no significance ( P 〉 0.05). β-catenin expression was significantly correlated with tumor differentiation status. Tumors with regional nodal metastasis showed higher abnormal staining rate (92.5 % ) than those without nodal involvement(59.0% )( P 〈 0.01).The expression of β-catenin was not relevant to depth or size of tumors. Condusion Abnormal expression of β-catenin is associated with invasion and metastasis of colon carcinoma, and is an important factor in development of highly invasive tumor. β-catenin could be used as an important marker of colon carcinoma.
出处 《哈尔滨医科大学学报》 CAS 北大核心 2005年第4期349-351,共3页 Journal of Harbin Medical University
关键词 Β-CATENIN 结肠癌 组织芯片 免疫组织化学 β-catenin colon carcinoma tissue microarrays immunohistochemistry
  • 相关文献

参考文献8

  • 1Iwamoto M, Ahnen DJ, Franklin WA, et al. Expression of β-catenin and full-length APC protein in normal and neoplastic colonic tissues[J].Carcinogenesis, 2000,21 (11):1935-1940.
  • 2Schraml P, Kononen J, Bubendorf L, et al. Tissue microarrays for gene amplification surveys in many different tumor types[J]. Clini Cancer Res, 1999,5(8): 1966-1975.
  • 3Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma[J]. Lab Inves,2000,80(12): 1943-1949.
  • 4Takayama T,Shiozaki H, Doki Y, et al. Aberrant expression and phosphorglation of beta-catenin in human colorectal cancer [J]. Br J Cancer, 1998,77(4) :605-613.
  • 5Hao X, Tomlinson I, I,Ilyias M, et al. Reciprocity between membranous and nuclear expression of β-catenin in colorectal tumors[J]. Virchows Arch,1997,431(3) :167-172.
  • 6Kobayashi M, Honma T, Matsuda Y, et al. Nuclcar translocation of beta-catenin in colorectal cancer[J]. Cancer,2000,82(10): 1689-1693.
  • 7王宏,黎卫平,高云荷.子宫内膜癌中β-连环素表达及与预后的关系[J].临床与实验病理学杂志,2003,19(2):156-159. 被引量:7
  • 8Brooks G, Wilson RE, Dooley TP, et al. Protein kinase C down regulation, and not transient activation, correlates with melanocyte growth[J].Cancer Res, 1991,51 (12) :3281-3288.

二级参考文献6

  • 1Machin P,Catasus L,Pons C, et al. CTNNB1 mutations and beta-catenin expression in endometrial carcinomas. Hum Pathol,2002,33:206~12.
  • 2Brabletz T,Jung A,Hermann K,et al. Alteredcadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and differentiation. Pathol Res Pract,1998,194:701~4.
  • 3Garcia-Rostan G,Tallini G,Herrero A, et al. Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma. Cancer Res, 1999,59:81811~5.
  • 4Yokoyama Y,Sagara M,Sato S,et al.Value of glutathione S-transferase pi and the oncogeng products c-Jun,c-Fos ,c-H-ras, and c-Myc as a prognosis indicater in endometrial carcinomas. Gynecol Oncol, 1998,68:3280~7.
  • 5Nagai N. Evaluation of prognostic factors in gynecological cancer examined by molecularbiological study. Gan To Kagaku Ryoho,1996,23(8):1004~9.
  • 6Wu Y,Renard CA,Apiou F, et al.Recurrent allelic deletions at mouse chromosomes 4 and 14 in myc-inducced liver tumors. Oncogene,2002,21:1518~26.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部